Gilead Calistoga LLC owns three of the patents, and Gilead is the exclusive licensee of two others owned by Lilly’s ICOS Corp. unit, according to a complaint filed Thursday in the US District Court for the District of Delaware.
The Lilly patents expire in July 2025 and August 2025. Of the Gilead patents, two expire in March 2033, and one in September 2033, court ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.